Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Organogenesis Holdings Inc.ORGO · Entity 6275 | Director | December 16, 2025 | December 18, 2025 |
| Perfumania Holdings, Inc.PERF · Entity 172127 | Director · 10% owner | October 11, 2017 | October 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Organogenesis Holdings Inc.
Report date December 16, 2025 · Filed December 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,565,591 |
Reported balance
After 2025-12-16 transaction · row 1
1 source rowRow 1 · 2025-12-16 · Sale · Disposed 200,000 · Balance 2,565,591 F1: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.24, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy GN 2016 Family Trust u/a/d August 12, 2016 | 918,680 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 918,680 |
| Class A Common StockSEC Table I · non-derivative | IndirectBy GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 7,928,570 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 7,928,570 |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Glenn Nussdorf 10 Year Follow On Trust Dated 11-1-1998 | 335,719 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 335,719 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.24, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Perfumania Holdings, Inc.
Report date October 11, 2017 · Filed October 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 0 |
Reported balance
After 2017-10-11 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2017-10-11 · Disposition to issuer · Disposed 8,362,032 · Balance 0 F1: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. F2: Represents all the issuer shares held by the limited liability company before cancellation. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy LLC | 1,000 |
Reported balance
After 2017-10-11 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-10-11 · Grant · Acquired 1,000 · Balance 1,000 F3: Pursuant to the Chapter 11 bankruptcy proceeding, upon effectiveness of the issuer's Plan of Reorganization, a total of $14,263,460, which the reporting person and his affiliates were required to contribute to the limited liability company, was provided to the issuer in consideration of the issuance of these shares. F4: Represents all the issuer shares held by the limited liability company. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $23.94 · Expires 2018-08-11 | Direct | 0 |
Reported balance
After 2017-10-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-10-11 · Disposition to issuer · Disposed 443,757 · Balance 0 F1: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. |
Filing footnotes · ownership attribution and instrument terms
F1: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization.
F2: Represents all the issuer shares held by the limited liability company before cancellation. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
F3: Pursuant to the Chapter 11 bankruptcy proceeding, upon effectiveness of the issuer's Plan of Reorganization, a total of $14,263,460, which the reporting person and his affiliates were required to contribute to the limited liability company, was provided to the issuer in consideration of the issuance of these shares.
F4: Represents all the issuer shares held by the limited liability company. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2021 Filed May 10, 2021 21:56 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | OtherClass A Common Stock | 23,855,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000040 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,173,793 F1 · kind: Reflects a pro rata distribution by Organo PFG LLC to its members. F2 · shares: The reported securities were distributed by Organo PFG LLC, which is a member of the Group (as defined below). Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 20:15 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | SaleClass A Common Stock | 200,000 | $3.25 | $650,000.00 |
DisclosureSEC source: 0001661181-21-000011 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,594,976 F1 · shares: The reported securities sold were held directly by Alan A. Ades, who is a member of the Group (as defined below). On November 17, 2020, Mr. Ades purchased shares of Class A common stock of Organogenesis Holdings Inc. at a price of $3.25 per share, including (i) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of one of his sons and (ii) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of an entity that is managed by Mr. Ades' son-in-law. This Form 4 reflects the sales of such shares. Read SEC document |
| December 29, 2020 Filed Feb 12, 2021 18:32 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 251,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000007 · edgar.xml · nonDerivative · entry 2 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,794,976 F1 · shares: Such shares were previously held by GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 (the "GN 2016 GRAT"), a member of the Group (as defined below). On December 29, 2020, the GN 2016 GRAT distributed 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to Glenn H. Nussdorf in satisfaction of its annuity obligation and in an exempt transaction pursuant to Rule 16a-13. On December 29, 2020, Glenn H. Nussdorf transferred 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to GN 2016 Family Trust u/a/d August 12, 2016 for no consideration. Each of Glenn H. Nussdorf and GN 2016 Family Trust u/a/d August 12, 2016 is a member of the Group. Read SEC document |
| December 29, 2020 Filed Feb 12, 2021 18:32 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GiftClass A Common Stock | 251,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001661181-21-000007 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,543,546 F1 · shares: Such shares were previously held by GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 (the "GN 2016 GRAT"), a member of the Group (as defined below). On December 29, 2020, the GN 2016 GRAT distributed 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to Glenn H. Nussdorf in satisfaction of its annuity obligation and in an exempt transaction pursuant to Rule 16a-13. On December 29, 2020, Glenn H. Nussdorf transferred 251,430 shares of Class A Common Stock of Organogenesis Holdings Inc. to GN 2016 Family Trust u/a/d August 12, 2016 for no consideration. Each of Glenn H. Nussdorf and GN 2016 Family Trust u/a/d August 12, 2016 is a member of the Group. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 16:55 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 347,153 | $3.25 | $1,128,247.25 |
DisclosureSEC source: 0001661181-20-000037 · edgar.xml · nonDerivative · entry 2 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Robert Harry Erani Frick Trust Disclosed balance after: 68,794,976 F2 · shares: The reported securities were purchased by the Robert Harry Erani Frick Trust (the "Trust") and are held indirectly by Dennis Erani, who is a member of the Group. Susan Erani, Dennis Erani's spouse, and Glenn Nussdorf are co-trustees of the Trust. Dennis Erani disclaims beneficial ownership of the securities held by the Trust, except to the extent of his pecuniary interest therein. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 16:55 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 486,000 | $3.25 | $1,579,500.00 |
DisclosureSEC source: 0001661181-20-000037 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,447,823 F1 · shares: The reported securities were purchased and are held directly by Alan A. Ades, who is a member of the Group. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 18:39 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 10,000 | $5.03 | $50,274.00 |
DisclosureSEC source: 0001661181-19-000016 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,961,823 F1 · shares: The reported securities were purchased and are held directly by Alan A. Ades, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $5.15, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| September 05, 2019 Filed Sep 5, 2019 20:11 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 5,000 | $4.53 | $22,664.00 |
DisclosureSEC source: 0001661181-19-000006 · edgar.xml · nonDerivative · entry 4 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,951,823 F5 · shares: The reported securities were purchased and are held directly by Albert Erani, who is a member of the Group. F6 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.52 to $4.55, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (6) to this Form 4. Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 20:11 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 50,000 | $4.62 | $231,190.00 |
DisclosureSEC source: 0001661181-19-000006 · edgar.xml · nonDerivative · entry 3 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,946,823 F1 · shares: The reported securities were purchased and are held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F4 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.37 to $4.92, inclusive. The reporting person undertakes to provide to ORGO, any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:11 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 100 | $4.25 | $425.00 |
DisclosureSEC source: 0001661181-19-000006 · edgar.xml · nonDerivative · entry 2 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,896,823 F3 · shares: The reported securities were purchased and are held directly by Dennis Erani, who is a member of the Group. Read SEC document |
| September 03, 2019 Filed Sep 5, 2019 20:11 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | PurchaseClass A Common Stock | 50,000 | $4.38 | $218,930.00 |
DisclosureSEC source: 0001661181-19-000006 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,896,723 F1 · shares: The reported securities were purchased and are held directly by Glenn H. Nussdorf, who is a member of the Group (as defined below). F2 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.48, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:19 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantCommon Stock | 182,841 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001661181-18-000049 · edgar.xml · nonDerivative · entry 3 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,846,723 F5 · price: Received by Glenn H. Nussdorf in connection with the Merger in exchange for 90,069 shares of common stock of Organogenesis previously held by Mr. Nussdorf. F6 · ownership.direct: The reported securities are held directly by Glenn H. Nussdorf, who is a member of the Group. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:19 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantCommon Stock | 781,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001661181-18-000049 · edgar.xml · nonDerivative · entry 2 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,663,882 F3 · price: Received by Albert Erani in connection with the Merger in exchange for 385,174 shares of common stock of Organogenesis previously held by Mr. Erani. F4 · ownership.direct: The reported securities are held directly by Albert Erani, who is a member of the Group. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:19 UTC | Organogenesis Holdings Inc. ORGO · Entity 6275 | GrantCommon Stock | 6,279,441 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001661181-18-000049 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,881,978 F1 · price: Received by Alan A. Ades in connection with the Issuer's business combination (the "Merger") with Organogenesis Inc. ("Organogenesis") in accordance with the terms of the Agreement and Plan of Merger dated as of August 17, 2018 among the Issuer, which was then referred to as Avista Healthcare Public Acquisition Corp., Avista Healthcare Merger Sub, Inc. and Organogenesis, in exchange for 3,093,320 shares of common stock of Organogenesis previously held by Mr. Ades. F2 · ownership.direct: The reported securities are held directly by Alan A. Ades, who is a member of the Group (as defined below). Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 16:02 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | Disposition to issuerWarrant · Derivative | 443,757 | $0.00 Strike: $23.94 | $0.00 |
DisclosureSEC source: 0000908662-17-000204 · edgar.xml · derivative · entry 3 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 443,757 shares Expires 2018-08-11 F1 · kind: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 16:02 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | GrantCommon Stock | 1,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000908662-17-000204 · edgar.xml · nonDerivative · entry 2 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 1,000 F3 · kind: Pursuant to the Chapter 11 bankruptcy proceeding, upon effectiveness of the issuer's Plan of Reorganization, a total of $14,263,460, which the reporting person and his affiliates were required to contribute to the limited liability company, was provided to the issuer in consideration of the issuance of these shares. F4 · shares: Represents all the issuer shares held by the limited liability company. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. F3 · price: Pursuant to the Chapter 11 bankruptcy proceeding, upon effectiveness of the issuer's Plan of Reorganization, a total of $14,263,460, which the reporting person and his affiliates were required to contribute to the limited liability company, was provided to the issuer in consideration of the issuance of these shares. F4 · balance_after: Represents all the issuer shares held by the limited liability company. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 16:02 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | Disposition to issuerCommon Stock | 8,362,032 | $0.00 | $0.00 |
DisclosureSEC source: 0000908662-17-000204 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 0 F1 · kind: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, these securities (which had no value) were cancelled for no consideration upon effectiveness of the issuer's Plan of Reorganization. F2 · shares: Represents all the issuer shares held by the limited liability company before cancellation. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:15 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | OtherCommon Stock | 8,362,032 | $0.00 | $0.00 |
DisclosureSEC source: 0000908662-17-000149 · edgar.xml · nonDerivative · entry 2 NUSSDORF GLENN H · CIK 0001244191 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By LLC Disclosed balance after: 8,362,032 F2 · balance_after: This represents all the issuer shares held by the limited liability company following the transfers by the reporting person and his siblings. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. F1 · ownership.nature: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, the shares (which have no value and will be cancelled for no consideration upon confirmation of the issuer's Plan of Reorganization) were transferred to a new limited liability company controlled by the reporting person and his siblings in exchange for membership interests in the limited liability company. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 18:15 UTC | Perfumania Holdings, Inc. PERF · Entity 172127 | OtherCommon Stock | 3,536,129 | $0.00 | $0.00 |
DisclosureSEC source: 0000908662-17-000149 · edgar.xml · nonDerivative · entry 1 NUSSDORF GLENN H · CIK 0001244191 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: In order to facilitate the reorganization of the issuer under Chapter 11 of the Bankruptcy Code, the shares (which have no value and will be cancelled for no consideration upon confirmation of the issuer's Plan of Reorganization) were transferred to a new limited liability company controlled by the reporting person and his siblings in exchange for membership interests in the limited liability company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.